The estimated Net Worth of Thomas C Chesterman is at least $388 Mille dollars as of 17 July 2017. Mr. Chesterman owns over 1,411 units of SenesTech Inc stock worth over $31,702 and over the last 8 years he sold SNES stock worth over $64,353. In addition, he makes $292,061 as Chief Financial Officer, Executive Vice President, Treasurer e Assistant Secretary at SenesTech Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Chesterman SNES stock SEC Form 4 insiders trading
Thomas has made over 3 trades of the SenesTech Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 1,411 units of SNES stock worth $7,253 on 17 July 2017.
The largest trade he's ever made was exercising 15,000 units of SenesTech Inc stock on 20 April 2017 worth over $7,500. On average, Thomas trades about 2,641 units every 9 days since 2016. As of 17 July 2017 he still owns at least 9,876 units of SenesTech Inc stock.
You can see the complete history of Mr. Chesterman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Thomas Chesterman biography
Thomas C. Chesterman serves as Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary of the Company. He has over 20 years of experience as the chief financial officer of a public company in the life science, technology and telecommunications industries. Most recently, he was the vice president and treasurer of General Communication Inc., a telecommunications company in Alaska, from 2013 to 2015. Previously, he was the chief financial officer of life science companies Bionovo Inc. from 2007 to 2012, Aradigm Corp. from 2002 to 2007 and Bio-Rad Laboratories, Inc. from 1996 to 2002. Mr. Chesterman is adept at a variety of capital market access techniques and has significant experience in developing the operational and financial infrastructures in companies to help support successful and rapid growth. Mr. Chesterman earned a bachelor’s degree from Harvard University and an M.B.A. from the University of California at Davis.
What is the salary of Thomas Chesterman?
As the Chief Financial Officer, Executive Vice President, Treasurer e Assistant Secretary of SenesTech Inc, the total compensation of Thomas Chesterman at SenesTech Inc is $292,061. There are 2 executives at SenesTech Inc getting paid more, with Kenneth Siegel having the highest compensation of $996,476.
How old is Thomas Chesterman?
Thomas Chesterman is 60, he's been the Chief Financial Officer, Executive Vice President, Treasurer e Assistant Secretary of SenesTech Inc since 2015. There are 8 older and 4 younger executives at SenesTech Inc. The oldest executive at SenesTech Inc is Marc Dumont, 76, who is the Independent Director.
What's Thomas Chesterman's mailing address?
Thomas's mailing address filed with the SEC is C/O SENESTECH, INC., 23460 N. 19TH AVE., STE 110, PHOENIX, AZ, 85027.
Insiders trading at SenesTech Inc
Over the last 8 years, insiders at SenesTech Inc have traded over $262,233 worth of SenesTech Inc stock and bought 999,146 units worth $1,973,633 . The most active insiders traders include Grover T Wickersham, Kenneth S Siegel e Jacob Steven Leach. On average, SenesTech Inc executives and independent directors trade stock every 24 days with the average trade being worth of $74,077. The most recent stock trade was executed by Jacob Steven Leach on 16 August 2021, trading 150,000 units of SNES stock currently worth $229,500.
What does SenesTech Inc do?
senestech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction. contrapest® is an innovative technology that targets the reproductive capabilities of norway and roof rats. as a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down. our delivery system is designed to minimize handler exposure, and contrapest® is dispensed inside tamper resistant bait stations, minimizing the risks to non-target species. as a versatile tool, contrapest® can be used within your integrated pest management program to help reduce reproduction and magnify the success of your ipm protocols or as a standalone, non-lethal solution for customers that are looking to reduce or eliminate their use of lethal methodologies. contrapest® is a restricted use pesticide, due to applicator expertise. please read and comply with all label instructions. fo
What does SenesTech Inc's logo look like?
Complete history of Mr. Chesterman stock trades at SenesTech Inc
SenesTech Inc executives and stock owners
SenesTech Inc executives and other stock owners filed with the SEC include:
-
Kenneth Siegel,
Chief Executive Officer, Director -
Kenneth S. Siegel,
CEO & Director -
Thomas Chesterman,
Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary -
Thomas C. Chesterman M.B.A.,
Exec. VP, CFO, Treasurer & Assistant Sec. -
Thomas C. Chesterman,
Exec. VP, CFO, Treasurer & Assistant Sec. -
Dr. Steven C. Krause Ph.D.,
Exec. VP of Sales & Marketing -
Kim Wolin,
Executive Vice President - Operations, Secretary -
Jamie Morrison,
Independent Chairman of the Board -
Kim Patrice Wolin,
Exec. VP of Operations & Sec. -
Jake Leach,
Independent Director -
K. Kavanagh,
Independent Director -
Phil Grandinetti,
Independent Director -
Julia Williams,
Independent Director -
Matthew Szot,
Independent Director -
Marc Dumont,
Independent Director -
Delphine Chiavarini,
Independent Director -
Steve Krause,
Executive Vice President of Sales and Marketing -
Nicole Williams,
Chief Strategy Officer -
Robert Blum,
Investor Relations -
Paul M. Palz,
VP & Corp. Controller -
Loretta Powers Mayer,
Chief Scientific Officer -
Grover T Wickersham,
Director -
Robert E Jr Ramsey,
Director -
Cheryl Ann Dyer,
Pres. & Chief Research Officer -
Jacob Steven Leach,
Director -
Nicole C Williams,
Chief Strategy Officer -
Joel Lee Fruendt,
Chief Executive Officer